Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema

Bibliographic Details
Main Authors:	Lauren Chen, MS, Kyle Owens, MD, Andrea Murina, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	JAAD Case Reports
Subjects:	anti-MDA5 antibody dermatomyositis rapidly progressive interstitial lung disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620305129

Similar Items

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
by: Yuki Hattori, et al.
Published: (2018-05-01)

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis
by: Yimin Li, et al.
Published: (2021-09-01)

Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
by: Zi Ying Li, et al.
Published: (2020-08-01)

Myositis-Related Interstitial Lung Disease: A Respiratory Physician’s Point of View
by: Yuko Waseda
Published: (2021-06-01)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021-06-01)

Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
by: Yuichi Ishikawa, et al.
Published: (2018-10-01)

Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
by: Porntip Intapiboon, et al.
Published: (2020-01-01)

Anti-MDA5 Positive Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease and Correlation between Serum Ferritin Level and Treatment Response
by: Daniela Noa Zohar, et al.
Published: (2019-01-01)

Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody–positive rapidly progressive interstitial pneumonia: Two case reports
by: Mayuko Ishiwari, et al.
Published: (2021-01-01)

Fulminant Course of Neuromyelitis Optica in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis: A Case Report
by: You-Ri Kang, et al.
Published: (2020-11-01)

Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
by: Toyoshi Yanagihara, et al.
Published: (2020-01-01)

Subacute cutaneous lupus erythematosus, and positive anti-MDA5 antibody in clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease: A case report and literature review
by: Wahinuddin Sulaiman, et al.
Published: (2021-06-01)

Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report
by: Kazuhiro Yamada, et al.
Published: (2018-01-01)

Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
by: Walter Conca, et al.
Published: (2020-12-01)

Anti-MDA5 Antibody-Positive Interstitial Pneumonia with Autoimmune Features Presenting as Amyopathic Hypodermatitic Dermatomyositis: A Case Report
by: Maria L. Mihailescu, et al.
Published: (2021-04-01)

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias
by: Hiroko Okabayashi, et al.
Published: (2017-10-01)

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
by: Junyu Liang, et al.
Published: (2021-02-01)

High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center
by: Linlin Huang, et al.
Published: (2021-09-01)

COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
by: Mengke Cao, et al.
Published: (2020-11-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
by: Tsz-Wing Yeung, et al.
Published: (2021-06-01)

Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
by: Cuihong Chen, et al.
Published: (2021-02-01)

Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features
by: Laurence Pacot, et al.
Published: (2020-03-01)

Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
by: Hidenori Ichiyasu, et al.
Published: (2017-01-01)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
by: Nouf Alqahtani, et al.
Published: (2021-09-01)

Rapidly progressive melanoma differentiation–associated protein 5–positive amyopathic dermatomyositis in an HIV-positive patient
by: Ashutosh Sharma, BSc, et al.
Published: (2017-03-01)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
by: Taisuke Isono, et al.
Published: (2021-01-01)

A Fatal Complication of Dermatomyositis: Spontaneous Pneumomediastinum
by: Ezgi Demirdöğen Çetinoğlu, et al.
Published: (2016-04-01)

Antimelanoma differentiation-associated gene 5 dermatomyositis associated with acute encephalopathy
by: Morgan Nguyen, BA, et al.
Published: (2021-07-01)

Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease
by: Lin Liang, et al.
Published: (2021-03-01)

Successful Immunoglobulin Treatment in Severe Cryptogenic Organizing Pneumonia Caused by Dermatomyositis
by: Dong Hoon Lee, et al.
Published: (2015-08-01)

Clinically amyopathic dermatomyositis presenting with isolated facial edema complicated by acute respiratory failure: a case report
by: Doo-Ho Lim, et al.
Published: (2021-01-01)

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2014-05-01)

Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis
by: Jeong Uk Lim, et al.
Published: (2017-08-01)

MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
by: Safi Alqatari, et al.
Published: (2018-04-01)

Case Report: Treatment of Anti-MDA5-Positive Amyopathic Dermatomyositis Accompanied by a Rapidly Progressive Interstitial Lung Diseases With Methylprednisolone Pulse Therapy Combined With Cyclosporine A and Hydroxychloroquine
by: Qia-Chun Zhang, et al.
Published: (2020-11-01)

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report
by: Xingguo Yang, et al.
Published: (2019-10-01)

Medical image of the week: subcutaneous calcification in dermatomyositis
by: Natt B
Published: (2016-12-01)

Juvenile Dermatomyositis with Generalized Edema
by: J Gordon Millichap
Published: (2001-06-01)